| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total liabilities and stockholders' equity | $184.7B | $186.0B | $190.1B | $194.3B | $198.8B | $204.4B | $212.7B | $221.4B |
| Total stockholders' equity | $49.1B | $50.1B | $50.1B | $49.8B | $50.8B | $54.2B | $54.6B | $55.2B |
| Retained earnings | $32.0B | $32.8B | $32.9B | $32.6B | $33.5B | $34.7B | $35.1B | $36.0B |
| Additional paid-in capital | $17.3B | $17.4B | $17.3B | $17.3B | $17.4B | $19.5B | $19.5B | $19.3B |
| Additional paid-in capital | $17.3B | $17.4B | $17.3B | $17.3B | $17.4B | $19.5B | $19.5B | $19.3B |
| Noncontrolling interests | $10.3B | $9.5B | $10.4B | $10.5B | $10.1B | $10.4B | $11.9B | $11.4B |
| Common stock | 3.2B | 3.2B | 21M | 3.2B | 3.2B | 3.2B | 3.2B | 3.2B |
| Common Stock Shares Issued | — | — | — | — | — | — | 2.1B | 2.1B |
| Accumulated other comprehensive income (loss) | -$171.0M | -$131.0M | -$126.0M | -$114.0M | -$70.0M | -$72.0M | -$9.0M | -$34.0M |
| Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | $21.0M | $21.0M | $21.0M | $21.0M | $21.0M | $21.0M | $21.0M | $21.0M |
| Common Stock Par Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
| Redeemable noncontrolling interests | $0.0 | $0.0 | $401.0M | $61.0M | $49.0M | $0.0 | $0.0 | — |
| Share Price | — | — | — | $9.50 | — | — | — | — |